Literature DB >> 18245110

EULAR recommendations for the management of Behçet disease.

G Hatemi1, A Silman, D Bang, B Bodaghi, A M Chamberlain, A Gul, M H Houman, I Kötter, I Olivieri, C Salvarani, P P Sfikakis, A Siva, M R Stanford, N Stübiger, S Yurdakul, H Yazici.   

Abstract

OBJECTIVES: To develop evidence-based European League Against Rheumatism (EULAR) recommendations for the management of Behçet disease (BD) supplemented where necessary by expert opinion.
METHODS: The multidisciplinary expert committee, a task force of the EULAR Standing Committee for Clinical Affairs (ESCCA), consisted of nine rheumatologists (one who was also a clinical epidemiologist and one also a Rehabilitation Medicine doctor), three ophthalmologists, one internist, one dermatologist and one neurologist, representing six European countries plus Tunisia and Korea. A patient representative was also present. Problem areas and related keywords for systematic literature research were identified. Systematic literature research was performed using Medline and the Cochrane Library databases from 1966 through to December 2006. A total of 40 initial statements were generated based on the systematic literature research. These yielded the final recommendations developed from two blind Delphi rounds of voting.
RESULTS: Nine recommendations were developed for the management of different aspects of BD. The strength of each recommendation was determined by the level of evidence and the experts' opinions. The level of agreement for each recommendation was determined using a visual analogue scale for the whole committee and for each individual aspect by the subgroups, who consider themselves experts in that field of BD. There was excellent concordance between the level of agreement of the whole group and the "experts in the field".
CONCLUSION: Recommendations related to the eye, skin-mucosa disease and arthritis are mainly evidence based, but recommendations on vascular disease, neurological and gastrointestinal involvement are based largely on expert opinion and uncontrolled evidence from open trials and observational studies. The need for further properly designed controlled clinical trials is apparent.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18245110     DOI: 10.1136/ard.2007.080432

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  172 in total

Review 1.  Pediatric vasculitis.

Authors:  Ezgi Deniz Batu; Seza Ozen
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

Review 2.  Adamantiades-Behcet's disease-complicated gastroenteropathy.

Authors:  Qing-Jun Wu; Feng-Chun Zhang; Xuan Zhang
Journal:  World J Gastroenterol       Date:  2012-02-21       Impact factor: 5.742

Review 3.  Behçet's syndrome.

Authors:  Yusuf Yazici; Sebahattin Yurdakul; Hasan Yazici
Journal:  Curr Rheumatol Rep       Date:  2010-12       Impact factor: 4.592

4.  Oral ulcer activity in Behcet's disease: Poor medication adherence is an underestimated risk factor.

Authors:  Gonca Mumcu; Fatma Alibaz-Öner; Sibel Yılmaz Öner; Gülsen Özen; Pamir Atagündüz; Nevsun İnanç; Leyla Köksal; Tülin Ergun; Haner Direskeneli
Journal:  Eur J Rheumatol       Date:  2017-06-01

5.  Diagnosis and treatment of cerebral vasculitis.

Authors:  Peter Berlit
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

6.  Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet's disease.

Authors:  Antonio Vitale; Giacomo Emmi; Giuseppe Lopalco; Claudia Fabiani; Stefano Gentileschi; Elena Silvestri; Di Scala Gerardo; Florenzo Iannone; Bruno Frediani; Mauro Galeazzi; Giovanni Lapadula; Donato Rigante; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2017-04-11       Impact factor: 2.980

Review 7.  [Ocular involvement in rheumatoid arthritis, connective tissue diseases and vasculitis].

Authors:  I Kötter; N Stübiger; C Deuter
Journal:  Z Rheumatol       Date:  2017-10       Impact factor: 1.372

8.  Behcet's disease with major vascular involvement.

Authors:  Linda N Geng; Delaney Conway; Scott Barnhart; Johannes Nowatzky
Journal:  BMJ Case Rep       Date:  2013-11-08

9.  Serious Coronary Thrombosis and Pulmonary Artery Thrombosis Revealing Behçet's Disease.

Authors:  Di Liu; Wangbin Ning; Xiaoxia Zuo
Journal:  Arch Rheumatol       Date:  2018-01-29       Impact factor: 1.472

Review 10.  The spectrum of nervous system involvement in Behçet's syndrome and its differential diagnosis.

Authors:  Aksel Siva; Sabahattin Saip
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.